Author details

Full Name

Tina Young Poussaint

Affiliation

ORCID

Career Start Year

1990

Papers

158

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36858729	Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop.	Lancet Oncol	2023
36342679	Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.	JAMA Neurol	2023
36124689	Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group.	Neuro Oncol	2023
37945573	Automated temporalis muscle quantification and growth charts for children through adulthood.	Nat Commun	2023
37707414	Complications of Cancer Therapy in Children: A Comprehensive Review of Neuroimaging Findings.		2023
37864711	Review of imaging recommendations from Response Assessment in Pediatric Neuro-Oncology (RAPNO).		2023
37609311	Noninvasive molecular subtyping of pediatric low-grade glioma with self-supervised transfer learning.	medRxiv	2023
36519599	Imaging of pediatric brain tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee/ASPNR White Paper.	Pediatr Blood Cancer	2023
37466939	Neurological and Psychological Sequelae Associated With Multisystem Inflammatory Syndrome in Children.	JAMA Netw Open	2023
36574316	Reply.	AJNR Am J Neuroradiol	2023
36562555	Imaging of pediatric spine and spinal cord tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee/ASPNR White Paper.		2023
37121627	Summary of the 2022 ACR Intersociety Meeting.		2023
34935967	Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).	Neuro Oncol	2022
35710121	The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know.		2022
35901835	Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.	Lancet Oncol	2022
35438562	MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study.	Radiology	2022
35536420	Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [F]FDG: version 1.0.	European Journal of Nuclear Medicine and Molecular Imaging	2022
34174070	Deep learning-based automatic tumor burden assessment of pediatric high-grade gliomas, medulloblastomas, and other leptomeningeal seeding tumors.	Neuro Oncol	2022
35307742	Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study.	Neuro Oncol	2022
35210278	ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium.		2022
34551090	Corrigendum to: Deep learning-based automatic tumor burden assessment of pediatric high-grade gliomas, medulloblastomas, and other leptomeningeal seeding tumors.	Neuro Oncol	2021
33631016	A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.	Neuro Oncol	2021
33666649	Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome.	JAMA Neurol	2021
33547201	A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study.	Clin Cancer Res	2021
33405376	A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).	Pediatr Blood Cancer	2021
35062704	Multisystem Inflammatory-like Syndrome in a Child Following COVID-19 mRNA Vaccination.	Vaccines (Basel)	2021
34392363	Machine Assist for Pediatric Posterior Fossa Tumor Diagnosis: A Multinational Study.	Neurosurgery	2021
32502457	Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.	Lancet Oncol	2020
32009149	A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study.	Neuro Oncol	2020
32241771	Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.	AJNR Am J Neuroradiol	2020
32393959	Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.	Neuro Oncol	2020
32381545	MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma.	AJNR Am J Neuroradiol	2020
32816765	Deep Learning for Pediatric Posterior Fossa Tumor Detection and Classification: A Multi-Institutional Study.	AJNR Am J Neuroradiol	2020
32502459	Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.	Lancet Oncol	2020
32502458	Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.	Lancet Oncol	2020
31151904	Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.	Lancet Oncol	2019
31582042	Primary Neoplasms of the Pediatric Brain.	Radiologic Clinics of North America	2019
30530829	Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network.		2019
30523141	MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma.	AJNR Am J Neuroradiol	2019
30926117	Indications and Imaging Modality of Choice in Pediatric Headache.	Neuroimaging Clinics of North America	2019
30810873	Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium.	J Neurooncol	2019
31472183	Brainstem Injury in Pediatric Patients Receiving Posterior Fossa Photon Radiation.	Int J Radiat Oncol Biol Phys	2019
29329453	Response to Harreld re: "Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee".	Neuro Oncol	2018
28449033	Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee.	Neuro Oncol	2018
29619963	National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.	Int J Radiat Oncol Biol Phys	2018
29090526	A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.	Pediatr Blood Cancer	2018
29301780	Multiparametric Analysis of Permeability and ADC Histogram Metrics for Classification of Pediatric Brain Tumors by Tumor Grade.	AJNR Am J Neuroradiol	2018
27633807	Automated Processing of Dynamic Contrast-Enhanced MRI: Correlation of Advanced Pharmacokinetic Metrics with Tumor Grade in Pediatric Brain Tumors.	AJNR Am J Neuroradiol	2017
28339824	A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.	Neuro Oncol	2017
28360212	Correlation of F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.		2017